| 1 |
35091445 | Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer. | 2022 Apr 1 |
1 |
| 2 |
35449134 | PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. | 2022 Apr 21 |
1 |
| 3 |
34026621 | IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer. | 2021 |
5 |
| 4 |
34760687 | Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer. | 2021 |
1 |
| 5 |
32324337 | CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions. | 2020 Jun |
1 |
| 6 |
33193355 | "Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation". | 2020 |
1 |
| 7 |
31781109 | Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp620 Risk Allele Drive the Expansion of FOXP3+ Regulatory T Cells and PD-1 Expression. | 2019 |
1 |
| 8 |
28475007 | TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas. | 2017 May |
3 |
| 9 |
19651643 | PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. | 2009 Sep |
2 |